Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 227-177-9 | CAS number: 5698-98-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP guidline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- mouse local lymph node assay (LLNA)
- Species:
- mouse
- Strain:
- CBA
- Sex:
- female
- Details on test animals and environmental conditions:
- nulliparous, non pregnant
TEST ANIMALS
- Source: TOXI-COOP ZRT, H-1103, Budapest, Cserkesz u. 90
- Age at study initiation: 8 -11 weeks
- Weight at study initiation: 15.7 -20.6 g
- Housing: 4 animals/cage
- Diet: ad libitum
- Water: ad libitum
- Acclimation period: 7 or 14 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22+- 3
- Humidity (%): 30 - 70
- Photoperiod (hrs dark / hrs light): 12/12 - Vehicle:
- other: aqueous 1% Pluronic PE9200
- Concentration:
- - three groups received the Magnesium acrylate solution at 99%, 50% or 25%
- the negative control group received the vehicle (aqueous 1% Pluronic PE9200) only,
- the positive control received 25% alpha-Hexylcinnamaldehyde (HCA),
- the negative control group for the positive control group received aceton: olive oil 4:1 (v/v) - No. of animals per dose:
- four
- Details on study design:
- RANGE FINDING TESTS:
- Compound solubility: some precipitation on the skin of the ear
- Irritation: no
- Lymph node proliferation response: no
On the basis of a pilot study a formulation of the test item with 1% Pluronic PE9200 was chosen so t
hat the test item was sufficiently applicable on the ears of the animals.
Each concentration was applied on the external surface of each ear (25 μl/ear) of the animals for three co
nsecutive days (day1, 2, 3).
There was no treatment on days 4, 5 and 6. On day 6, the cell proliferation in the local lymph nodes
was measured by determing incorporation of tritiated methyl thymidine and the obtained values were
used to calculate stimulation indices. - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- Positive control results:
- Larger lymph nodes and a higher stimulation index than the control were observed in the positive control group.
- Parameter:
- SI
- Remarks on result:
- other: negative control: 1.0, positive control: 14.2, 99% test item: 0.7, 50% test item: 0.3, 25% test item: 0.9, negative control: 1.0
- Parameter:
- other: disintegrations per minute (DPM)
- Remarks on result:
- other: negative control: 619/node, positive control: 8790.9/node, 99% test item: 239.6/node, 50% test item: 107.9/node, 25% test item: 326.4/node, negative control: 344.8/node
- Parameter:
- SI
- Value:
- 0.7
- Test group / Remarks:
- test item conc. of 99%
- Parameter:
- SI
- Value:
- 0.3
- Test group / Remarks:
- test item conc. of 50%
- Parameter:
- SI
- Value:
- 0.9
- Test group / Remarks:
- test item conc. of 25%
- Interpretation of results:
- GHS criteria not met
- Remarks:
- Migrated information
- Conclusions:
- Under the conditions of the present Local Lymph Node Assay the magnesium acrylate solution of 46.41% content tested at the maximum attainable concentration of 99% and at concentrations of 50% and 25% as homogenous formulations in aqueous 1% Pluronic, was shown to have no
sensitization potential (non-sensitizer). - Executive summary:
A formulation of 46.41 % Magnesium acrylate in water was supplied by the sponsor for testing the sensitization potential. On the basis of a pilot study a formulation of the test item with 1% Pluronic PE9200 (w/v) was chosen so that the test item was sufficiently applicable on the ears of the animals. In the main assay 24 female CBA/Ca mice were allocated to six groups of four animals each:
- three groups received the Magnesium acrylate solution at 99%, 50% or 25% (v/v),
- the negative control group received the vehicle (aqueous 1% Pluronic PE9200) only,
- the positive control received 25% alpha-Hexylcinnamaldehyde (HCA),
- the negative control group for the positive control group received aceton: olive oil, 4:1 (v/v).
Each substance was applied on the external surface of each ear (25 µl/ear) of the animals for three consecutive days (day1, 2, 3). There was no treatment on days 4, 5 and 6. On day 6, the cell proliferation in the local lymph nodes was measured by determing incorporation of tritiated methyl thymidine and the obtained values were used to calculate stimulation indices:
negative control: 1.0,
positive control: 14.2,
99% test item: 0.7,
50% test item: 0.3,
25% test item: 0.9,
negative control: 1.0.
No significant loss of body weight was observed in any treatment group.
No mortality, no obvious signs of systemic toxicity or irritation were observed in any treatment groups.
Loss of hair was observed in the 99% dose group from day 1 to day 5.
Under the conditions of the present Local Lymph Node Assay the magnesium acrylate solution of 46.41% content tested at the maximum attainable concentration of 99% and at concentrations of 50% and 25% as homogenous formulations in aqueous 1% Pluronic PE9200, was shown to have no sensitization potential.
Thus magnesium acrylate is a non-sensitizer.
Reference
No significant loss of body weight was observed in any treatment group.
No mortality, no obvious signs of systemic toxicity or irritation were observed in any treatment groups.
Loss of hair was observed in the 99% dose group from day1 to day 5.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
- Migrated from Short description of key information:
Under the conditions of a Local Lymph Node Assay (OECD Guideline 429) the magnesium acrylate solution of 46.41% content tested at the maximum attainable concentration of 99% and at concentrations of 50% and 25% as homogenous formulations in aqueous 1% Pluronic PE9200, was shown to have no sensitization potential.
Thus magnesium acrylate is a non-sensitizer.
Justification for selection of skin sensitisation endpoint:
key study
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
Based on the available LLNA study, magnesium acrylate is a non-sensitizer and does not need to be classified and labelled according to
EC regulation 1272/2008, EEC Directives 67/548 and 1999/45.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
